AtriCure (ATRC) EPS (Basic) (2016 - 2025)
AtriCure (ATRC) has disclosed EPS (Basic) for 16 consecutive years, with $0.04 as the latest value for Q4 2025.
- On a quarterly basis, EPS (Basic) rose 112.12% to $0.04 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.24, a 74.74% increase, with the full-year FY2025 number at -$0.24, up 74.74% from a year prior.
- EPS (Basic) was $0.04 for Q4 2025 at AtriCure, up from -$0.01 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $2.15 in Q3 2021 to a low of -$0.38 in Q1 2021.
- A 5-year average of -$0.09 and a median of -$0.18 in 2024 define the central range for EPS (Basic).
- Peak YoY movement for EPS (Basic): soared 2054.55% in 2021, then tumbled 133.33% in 2023.
- AtriCure's EPS (Basic) stood at -$0.3 in 2021, then surged by 70.0% to -$0.09 in 2022, then crashed by 133.33% to -$0.21 in 2023, then crashed by 57.14% to -$0.33 in 2024, then surged by 112.12% to $0.04 in 2025.
- Per Business Quant, the three most recent readings for ATRC's EPS (Basic) are $0.04 (Q4 2025), -$0.01 (Q3 2025), and -$0.13 (Q2 2025).